IP Library › Granted Patent US 12,181,390
Granted Patent B2
US 12,181,390 · App. 18/364,392 · Granted Dec 31, 2024

Substance labeling patch, method and apparatus for tissue diagnosis using the same

Inventors: Dong Young Lee (Yongin-si, KR); Chan Yang Lim (Seongnam-si, KR); Kyung Hwan Kim (Yongin-si, KR)
Assignee: NOUL CO., LTD.
G01N1/312B01L3/00C07K16/3061C12Q1/6844C12Q1/6848C12Q1/686C12Q1/701G01N1/30G01N1/31G01N15/06G01N15/14G01N21/77G01N33/4833G01N33/49G01N33/5082G01N33/52G01N33/5304G01N33/533G01N33/558G01N33/574G01N33/60G06T7/0012G06T7/0014B01L3/505B01L7/52G01N2001/302G01N15/01G01N15/075G01N2021/7723G01N2021/7786
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,181,390
App. No.
18/364,392
Granted
Dec 31, 2024
Kind
B2
Abstract

The present disclosure relates to a tissue diagnosis device including a plate supporter configured to support a plate on which a reaction region is placed and a sample is placed in the reaction region, a patch controller configured to support the patch which contains a labeling substance that specifically labels the target substance, and control a position of the patch relative to the reaction region so that the patch provides the labeling substance to the reaction region, and a target substance detector configured to detect the labeling substance and detect the target substance included in the tissue sample.

Claims (36)

1. A tissue diagnosis method for detecting a target substance from a tissue sample by using a patch which includes a mesh structural body forming micro-cavities and is configured to contain a substance in the micro-cavities, the tissue diagnosis method comprising:

placing the tissue sample in a reaction region;

providing a fluorescence labeling substance for specifically labeling the target substance to the tissue sample by using the patch which contains the fluorescence labeling substance; and

detecting the fluorescence-labeled target substance from the tissue sample.

2. The tissue diagnosis method of claim 1 , wherein the fluorescence labeling substance is a fluorescence labeling complex that includes a reaction derivative that reacts specifically with the target substance and a fluorescence marker for detecting the target substance.

3. The tissue diagnosis method of claim 1 , wherein the detecting of the fluorescence-labeled target substance is performed by acquiring a fluorescence image of the tissue sample.

4. The tissue diagnosis method of claim 1 , wherein:

the target substance is a target base sequence included in the tissue sample; and

the fluorescence labeling substance includes a fluorescence-labeled nucleic acid probe, the nucleic acid probe binding complementarily to the target base sequence.

5. The tissue diagnosis method of claim 1 , wherein:

the target substance is a target protein included in the tissue sample; and

the fluorescence labeling substance include a fluorescence-labeled antibody, the antibody binds specifically to the target protein.

6. The tissue diagnosis method of claim 1 , wherein the providing of the fluorescence labeling substance to the tissue sample includes:

contacting the patch containing the fluorescence labeling substance with the tissue sample; and

when the patch is in contact with the tissue sample, the fluorescence labeling substance is allowed to move to the reaction region.

7. The tissue diagnosis method of claim 6 , wherein:

the providing of the fluorescence labeling substances to the tissue sample further includes separating the patch containing the fluorescence labeling substances from the tissue sample; and

when the patch is separated from the tissue sample, a residual fluorescence labeling substance that has not bound to the target substance of the fluorescence labeling substance is removed from the reaction region.

8. The tissue diagnosis method of claim 1 , wherein the detecting of the fluorescence-labeled target substance is performed by measuring an amount of fluorescence emitted from the target substance included in the tissue sample.

9. The tissue diagnosis method of claim 1 , wherein the detecting of the fluorescence-labeled target substance includes obtaining information on distribution of the target substance in the tissue sample.

10. A tissue diagnosis method for detecting a target substance from a tissue sample by using a patch which includes a mesh structural body forming micro-cavities and is configured to contain a substance in the micro-cavities, the tissue diagnosis method comprising:

placing the tissue sample in a reaction region;

providing a first fluorescence labeling substance for specifically labeling a first target substance to the tissue sample by using the patch which contains the first fluorescence labeling substance; and

providing a second fluorescence labeling substance for specifically labeling a second target substance to the tissue sample by using a patch that contains the second fluorescence labeling substance.

11. The tissue diagnosis method of claim 10 , wherein:

a wavelength band from which fluorescence emitted from the first

fluorescence labeling substance is detected and a wavelength band from which

fluorescence emitted from the second fluorescence labeling substance is detected are

different from each other; and

the tissue diagnosis method further includes, after the providing of the second florescence labeling substance to the tissue sample, detecting the first target substance and the second target substance included in the tissue sample.

12. The tissue diagnosis method of claim 10 , further comprising:

after the providing of the first fluorescence labeling substance to the tissue sample, detecting the first target substance included in the tissue sample by detecting fluorescence emitted from the first fluorescence labeling substance; and

after the providing of the second fluorescence labeling substance to the tissue sample, detecting the second target substance included in the tissue sample by detecting fluorescence emitted from the second fluorescence labeling substance.

13. The tissue diagnosis method of claim 12 , wherein:

a wavelength band from which the fluorescence emitted from the first fluorescence labeling substance is detected and a wavelength band from which the fluorescence is emitted from the second fluorescence labeling substance is detected at least partially overlap each other; and

the detecting of the fluorescence emitted from the second fluorescence labeling substance is performed by comparing fluorescence detected from the tissue sample after the second fluorescence labeling substance is provided to the tissue sample and fluorescence detected from the tissue sample before the second fluorescence labeling substance is provided to the tissue sample.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 23, 2023
From: LEE, DONG YOUNG; LIM, CHAN YANG; KIM, KYUNG HWAN
To: NOUL CO., LTD.
Reel/Frame 064684/0516 →
Priority Claims (7)
KR 10-2016-0069936 · Jun 4, 2016 · national
KR 10-2016-0069937 · Jun 4, 2016 · national
KR 10-2016-0069938 · Jun 4, 2016 · national
KR 10-2016-0095739 · Jul 27, 2016 · national
KR 10-2016-0118462 · Sep 13, 2016 · national
KR 10-2016-0144551 · Nov 1, 2016 · national
KR 10-2017-0024390 · Feb 23, 2017 · national
Continuity (3)
Continuation 16079236
Provisional Application 62298959 · Feb 23, 2016
Related Publication 20230393039A1 · Dec 7, 2023